Stabilization of cytoplasmic b-catenin is a hallmark of a variety of cancers. The stabilized b-catenin is able to translocate to the nucleus, where it acts as a transcriptional activator of T-cell factor (TCF)-regulated genes. Promoter studies indicate that overexpression of AP-1 activates the transcription of two b-catenin target genes, cyclin D1 and c-myc, by a mechanism independent of the AP-1 site, and fully dependent on the TCF-binding site. We further demonstrate that AP-1/b-catenin synergism is involved during serum-induced cyclin D1 transcriptional activation. We identify a TCF-binding site on the cyclin D1 promoter which binds in vivo a complex induced by serum, containing b-catenin, TCF4, c-Fos, c-Jun, JunB and JunD. This novel mechanism of interaction between two signalling cascades might contribute to the potentiation of malignancy.
Introduction b-Catenin is an important nuclear effector of the Wnt/ Wingless signalling pathway involved in the establishment of the dorso-ventral axis or the segmentation pattern in embryos (Gumbiner, 1995) . In the absence of a Wnt signal, the cytosolic pool of b-catenin is bound to Axin and the adenomatous polyposis coli protein, phosphorylated at the N-terminal Ser/Thr residues by casein kinase Ia and glycogen synthase kinase 3b and then rapidly degraded by the ubiquitination-proteasome system. In response to a Wnt signal, b-catenin phosphorylation is prevented, leading to the accumulation of the protein in the cytoplasm and in the nucleus, where it binds to and enhances transcriptional activation by proteins of the lymphoid enhancer factor (LEF)/T-cell factor (TCF) family (Giese and Grosschedl, 1993; Gumbiner, 1995; Clevers and van de Wetering, 1997; Billin et al., 2000) . Binding of b-catenin to LEF/TCF causes displacement of core-repressor complexes containing histone deacetylases (Billin et al., 2000) , and heterodimerization that allows interaction with the C-terminal transactivation domain of b-catenin leading ultimately to the activation of transcription of Wntresponsive genes Moon et al., 2002) . The coactivator function of b-catenin is induced by recruitment of the basal transcription machinery (Hecht et al., 1999) and is enhanced by synergistic cooperation with a number of other proteins such as coactivators, (Zhurinsky et al., 2000; Martin et al., 2002; Grueneberg et al., 2003; Wei et al., 2003) or proteins involved in chromatin remodeling and histone modification (Hecht et al., 2000; Miyagishi et al., 2000; Sun et al., 2000; Takemaru and Moon, 2000; Barker et al., 2001) . Not surprisingly, mounting evidence indicate that b-catenin is able to cross-talk with a variety of signalling cascades, such as those involving Rac GTPase, forkhead box O transcription factors or transforming growth factor (TGF)b (Eger et al., 2004; Esufali and Bapat, 2004; Chakladar et al., 2005; Essers et al., 2005) .
AP-1 is a dimeric transcription factor composed of one protein of the Jun family (c-Jun, JunB and JunD) and one protein of the Fos family (c-Fos, FosB, Fra-1, Fra-2), also involved in important regulatory cell functions, such as differentiation, proliferation and apoptosis (Eferl and Wagner, 2003) . Fos/jun heterodimers or Jun/Jun homodimers recognize a cis-acting element, the phorbol 12-myristate 13-acetate (TPA)-responsive element (TRE: TGAG/CTA), which is found in a number of promoters. Recent data suggest that the b-catenin and the AP-1 pathways may interact.
Specifically, c-Jun has been shown to physically interact with LEF-1, leading to a synergistic transactivation of the matrilysin promoter (Rivat et al., 2003) . Interaction of phosphorylated c-Jun with TCF4 on AP-1-binding sites was reported to be involved in the proliferation of colonic carcinoma cells (Nateri et al., 2005) .
In this study, we addressed the question of whether b-catenin itself is able to directly associate with AP-1 and whether such physical association may synergize for the transactivation of TCF/b-catenin-dependent genes. Fos and Jun proteins, the main AP-1 constituents, are able to modulate gene transcription by a mechanism independent from their binding to DNA, implying protein/protein interactions. For example, synergistic or antagonistic transcriptional effects related to AP-1 protein cooperation with p65 nuclear factor kappa B (NFkB) or Smad proteins have been described by us and other groups (Stein et al., 1993; Peron et al., 2001; Rahmani et al., 2001; Verrecchia et al., 2001; Ferrigno et al., 2002) . In this study, we show that b-catenin directly interacts with c-Jun and c-Fos proteins, both in vitro and in vivo, and that overexpression of c-Jun and c-Fos potentiates the transactivation of b-catenin target genes, such as cyclin D1 and c-myc, by a mechanism dependent on the TCF-binding element (TBE) and independent from the AP-1 site. Finally, we show that AP-1/b-catenin cooperation is involved in the transcriptional activation of the cyclin D1 gene by serum. These results underscore the remarkable complexity of the interaction between these two important signalling pathways.
Results

c-Jun and c-Fos associate with b-catenin in vivo
To evaluate whether AP-1/b-catenin associate in vivo, we performed co-immunoprecipitation experiments with extracts from Cos7 cells transiently cotransfected with c-Jun and c-Fos expression vectors and b-cat T41A, a plasmid that allows the expression of a mutated b-catenin able to translocate to the nucleus and to associate with TCF4. In these cells, immunoprecipitation with anti-c-Jun or anti-c-Fos followed by immunoblotting with anti-b-catenin antibody revealed the presence of an in vivo association between b-catenin and both AP-1 proteins (Figure 1a) . Similarly, association of endogenous AP-1 and b-catenin proteins was also demonstrated by immunoprecipitation in HepG2 cells (Figure 1b) , a cell line with activation of the nuclear b-catenin pathway owing to a stabilizing deletion of b-catenin (Carruba et al., 1999) . (Figure 2a and b) . The various c-Jun and c-Fos deletion fragments have been previously described (Kardassis et al., 1999; Ferrara et al., 2003) . Functional cooperation between b-catenin and AP-1 We next determined whether AP-1 has a functional implication in the transcriptional regulation of two b-catenin-dependent target genes, cyclin D1 and c-myc (He et al., 1998; Sasaki et al., 2003) , by using transient transfection experiments of their cognate promoter reporter together with c-Jun and/or c-Fos expression plasmids in HepG2 cells. The efficacy of the overexpression of c-Jun and c-Fos was verified by Western blot analysis of nuclear extracts obtained 48 h after electroporation (Figure 3a) . Co-expression of c-Jun or c-Fos with the pc-myc-Luc plasmid induced a 3.5-and six-fold increase of luciferase activity, respectively, whereas overexpression of both proteins induced a 12-fold increase of luciferase activity ( Figure 3b) . As an AP-1 element has been identified on the c-myc promoter (Iavarone et al., 2003) , we generated a pc-myc-AP1mut construct mutated on this site. Co-expression of c-Jun or c-Fos with pc-myc-AP-1mut increased the luciferase activity in a dose-dependent manner with a maximal 11-fold and 14-fold increase, respectively (Figure 3c To confirm these results in the context of another b-catenin/TCF-regulated promoter, we next utilized luciferase reporter constructs of the cyclin D1 promoter. Overexpression of c-Jun or c-Fos increased the transactivation mediated by a À963 cyclin D1 promoter construct by six-fold and eight-fold, respectively. Simultaneous overexpression of c-Jun and c-Fos did not further increase the promoter activity ( Figure 5a ). Cotransfection of TCF4DN with c-Fos or c-Jun completely blocked the stimulating effect indicating that the effect of AP-1 overexpression on the cyclin D1 promoter is again dependent on TCF/b-catenin-mediated transactivation ( Figure 5a ). To confirm that the AP-1-stimulating effect depended on the TCF-binding site (named TBE hereafter), we used the cyclin D1 promoter construct TBE0-4mut, which is mutated on the five proximal TBE sites. Accordingly, co-expression of c-Jun and c-Fos induced a weak activation of luciferase activity (1.5-fold, Figure 5b ), probably due to a modest activating effect of AP-1 on the TRE site. Finally, when the same experiments were carried out using the cyclin D1-AP1mut-ATFmut-Luc promoter construct mutated in the two main binding sites for AP-1, the TRE and the cAMP responsive element (CRE) sites, c-Jun and c-Fos overexpression still increased the promoter activity by 3.5-fold, and co-expression of TCF4DN reduced the stimulation by 63% (Figure 5c ). 
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In order to verify that our findings were not cell specific, we also studied the effect of AP-1 overexpression on the c-myc and cyclin D1 promoters in another cellular context, the HCT116 colon cancer cells, a cell line with constitutive activation of the nuclear b-catenin pathway . Accordingly, overexpression of c-Jun or c-Fos in HCT116 cells transfected with the pc-myc-AP1mut plasmid induced a 3.5-and 5-fold activation, respectively (Figure 6a ). Overexpression of both proteins did not induce a stronger effect, and co-expression of TCF4DN with both proteins induced only a 1.5 fold activation (Figure 6a ). The cyclin D1-AP1mut-ATFmut plasmid was activated 2.3-fold by c-Jun overexpression and 3.8-fold by c-Fos overexpression (Figure 6b ). Concomitant c-Jun and c-Fos overexpression induced a 3.6-fold activation, which was reduced to 1.3-fold in the presence of TCF4DN (Figure 6b ). Finally, no stimulation of luciferase activity was detected after overexpression of c-Jun and c-Fos on a cyclin D1 TBE0-4mut promoter construct (Figure 6c ). The cyclin D1 promoter is a target of AP-1/b-catenin cooperation during serum-induced proliferative response To evaluate the functional relevance of AP-1/b-catenin cooperation for the regulation of cell proliferation, cells were growth arrested by serum deprivation for 48 h and subsequently activated by serum addition, a context known to activate AP-1 and cell proliferation. As serum stimulated cellular proliferation more efficiently in HCT116 than in HepG2 cells (data not shown), we used HCT116 cells for these experiments. Activation of AP-1 by serum was checked by Western blot analysis (Supplementary data, Figure 1 ). To investigate whether the cyclin D1 promoter was a target of AP-1/b-catenin cooperation, we analysed by Electrophorestic mobility shift assays (EMSA) the binding of nuclear proteins to the five TBE previously identified on the promoter (Tetsu and McCormick, 1999) , using oligonucleotides specific for each DNA site. Although no specific binding to the TBE1-2, TBE3 and TBE4 sites could be detected in cells grown in serum (data not shown), one major DNA protein complex was detected on the TBE0 site located at À539-bp, which was eliminated by the addition of 100-fold excess unlabeled probe in the binding reaction, but not by an unlabeled mutated TBE0 probe. The specificity of the retarded band was also checked by supershift experiments. Addition of antibody to b-catenin in the binding reaction induced a supershift, whereas the TCF4 antibody inhibited partially the retarded band (Figure 7a ). The complex formation on the TBE0 site was almost completely abolished by serum deprivation, and was reinduced after serum stimulation, with a peak at 2 h followed by a decrease at 4 and 6 h ( Figure 7b ).
To determine whether AP-1 proteins are present in the DNA-binding complex after serum stimulation, competition experiments were performed with nuclear extracts from cells serum-stimulated for 2 h with the addition of a cold TRE probe specific of the consensus binding site for AP-1 proteins. Increasing the concentration of the cold TRE probe in the binding reaction progressively decreased the intensity of the retarded band, whereas a cold probe mutated in the TRE sequence did not compete for binding (Figure 8a ). These results indicated that part of the proteins binding to the TBE0 site are also able to bind with high affinity to the TRE probe, strongly suggesting that they are AP-1 proteins. To ascertain whether the TBE0 site is a target of AP-1 proteins, we next performed supershift experiments with nuclear extracts from HCT116 cells prepared after 2 h of serum stimulation. Addition of antibodies to c-Fos, JunB, JunD and c-Jun partially blocked the formation of the retarded band, indicating the presence of these proteins in the complex binding to TBE0 (Figure 8b) . To obtain direct evidence that AP-1 proteins bind to the endogenous TBE0 site of the cyclin D1 promoter, chromatin immunoprecipitation (ChIP) analysis was employed using cross-linked chromatin from HCT116 cells and a PCR primer pair for amplification of a 186-bp DNA fragment encompassing the TBE0 site of the cyclin D1 promoter. No PCR product was obtained with the TCF4 antibody by using a primer set that covers a non-regulatory region far 5 0 from the cyclin D1 promoter. With chromatin from serum-deprived cells, the PCR analysis specifically produced a 186-bp fragment when an antibody to TCF4 was used, while no specific signal was obtained with antibodies to b-catenin and to AP-1 proteins (Figure 9 AP-1 and b-catenin K Toualbi et al from 0, 2 and 4 h serum-stimulated cells ( Figure 9 ). As activation of b-catenin/TCF-dependent genes has been linked to the dissociation of the transcriptional repressors such as histone deacetylase 1 (HDAC1) from the LEF/TCF/b-catenin complex (Billin et al., 2000) , we also immunoprecipitated the chromatin samples with an HDAC1 antibody. As shown in Figure 9 , HDAC1 was present in the complex binding to the TBE0 site in unstimulated cells, in keeping with the fact that TCF4 is maintained in an inactive state in the absence of b-catenin signalling (Billin et al., 2000) . No PCR signal was obtained with the HDAC1 antibody with chromatin from 2 and 4 h stimulated cells, indicating that the complex at these times was indeed functionally active ( Figure 8 ). Altogether, these data indicate that AP-1/ b-catenin cooperation on the TBE0 site of the cyclin D1 promoter correlates with the activation of cyclin D1 during serum-induced proliferative response.
Discussion
There is emerging evidence that the b-catenin nuclear pathway may integrate multiple intracellular signals to coordinate cellular functions. Only scarce data are available on the interaction of the b-catenin signalling pathway with components of the AP-1 complex. Recently, Nateri et al. (2005) showed that phosphorylated c-Jun interacts with TCF4 on the c-jun promoter. We herein describe another mechanism of AP-1/ b-catenin cooperation that involves b-catenin itself and is strictly dependent on TCF-binding sites. Also, we demonstrate for the first time that b-catenin is able to directly interact not only with c-Jun, but also with c-Fos, an important dimeric partner of c-Jun. The physical interaction between b-catenin and both c-Jun and c-Fos was demonstrated by co-immunoprecipitations in vivo and by glutathione S-transferase (GST) pull-down assays in vitro. The co-immunoprecipitation experiments do not directly prove that the b-catenin interaction with AP-1 proteins was direct, because b-catenin has been reported previously to bind other proteins that are also potential partners of c-Jun and c-Fos, such as CBP/p300 (Miyagishi et al., 2000; Takemaru and Moon, 2000; Harris and Peifer, 2005) or the LIM-only protein (Morlon and Sassone-Corsi, 2003) . However, our in vitro pull-down assays clearly demonstrate a direct association between the armadillo repeats of b-catenin and the DNA-binding domain of c-Jun and the C-terminal domain of b-catenin with the N-terminal region of c-Fos. Thus, our findings identify two novel binding partners for the pool of nuclear b-catenin.
We further show that overexpression of c-Jun, c-Fos or both potentiates b-catenin transactivation on two well-identified b-catenin/TCF-regulated promoters, cyclin D1 and c-myc, in a manner strictly dependent on the presence of a TCF-binding element. The use of different fragments of c-Jun and c-Fos proteins indicated that the three functional domains of the proteins were indispensable for the stimulatory effect. For both proteins, deletion of the leucine zipper domain prevented the stimulation of b-catenin transactivation, indicating that a dimer formation was required. The transactivating domains of each protein may contribute to the stimulating effect, by amplifying the transactivation potency of a multiprotein complex. The synergistic effect of AP-1 is independent of the presence of an AP-1 site, as indicated by our studies utilizing c-myc or cyclin D1 promoter fragments deleted of the AP-1 site. AP-1 and b-catenin K Toualbi et al Therefore, the mechanism described herein is different from the cooperation between TCF4 and c-Jun recently described on the c-Jun promoter (Nateri et al., 2005) . This mechanism involved TCF4 interaction with phospho-c-Jun on the proximal AP-1 element of the promoter, required the presence of both the TCF and the AP-1 sites, and was not inhibited by TCF4DN as in our present study (Nateri et al., 2005) . The interaction of c-Jun with LEF-1, another protein of the TCF family, has also been described on the AP-1 site of the matrilysin promoter (Rivat et al., 2003) . Whether the molecular mechanisms underlying the AP-1 functional cooperation vary between the cyclin D1 and the c-myc promoter, as suggested by the stronger stimulating effect of AP-1 on the latter, are not clear. It is very likely that for each promoter, a specific chromatin environment may differentially influence the functional activity of the multiprotein regulatory complex formed on DNA. We checked that the enhanced transcriptional activity of b-catenin did not result from a destabilization from the plasma membrane (see Supplementary data, Figure 2 ), as described previously in a different experimental setting relying on a prolonged activation of AP-1 over several days (Fialka et al., 1996; Eger et al., 2000) . It is likely that the enhanced transcriptional activity resulted from the recruitment of nuclear b-catenin on DNA and the formation of one or several multiprotein complexes at TBE sites with enhanced transactivating capacity. Importantly, our study demonstrates that AP-1/ b-catenin cooperation is involved in the transcriptional induction of cyclin D1 in response to serum. We identified one TBE element previously mapped on the cyclin D1 promoter at À539-bp, which binds a complex induced by serum stimulation, containing b-catenin, TCF4, c-Jun, JunB, JunD and c-Fos, as indicated by our supershift experiments. The presence of c-Fos and Jun proteins in the complex formed in vivo on the TBE0 site of the cyclin D1 promoter was confirmed by ChIP analyses. JunB and JunD possess domains homologous to the three main functional domains of the c-Jun protein, including the DNA-binding domain, the region that we identified as the interactive part of the c-Jun protein with b-catenin, and the leucine zipper and transactivating domains, necessary for the cooperation. Accordingly a physical and functional interaction of b-catenin with JunB and JunD seems logical. Interestingly, the ChIP experiments showed that the recruitment of the AP-1 proteins in the complex binding to the TBE0 site of cyclin D1 at 2 h of serum stimulation was parallel to the appearance of b-catenin and the displacement of HDAC1, a transcriptional repressor known to bind to LEF/TCF on an inactive promoter (Billin et al., 2000) . Moreover, b-catenin as well as AP-1 proteins bound to the TBE0 site decreased at 4 h of stimulation, coincident with decreased binding on EMSA (see Figure 6b ). These observations therefore clearly indicate that AP-1 proteins associate in vivo with b-catenin for transactivating the cyclin D1 promoter after serum stimulation. The AP-1 proteins c-Jun, JunD and c-Fos have already been implicated as transcriptional activators of the cyclin D1 promoter through their binding to the TRE and/or the CRE elements (Brown et al., 1998; Albanese et al., 1999; Kane et al., 1999; Bakiri et al., 2000) , whereas the role of JunB is more debated (Albanese et al., 1995; Mechta et al., 1997; Bakiri et al., 2000) . Our present data strongly suggest that JunB may potentially play a positive role on cyclin D1 when cooperating with b-catenin. Altogether, our findings indicate that the role of individual AP-1 proteins on the cyclin D1 promoter is far more complicated than previously believed. Each AP-1 protein through its cooperation with other transcriptional factors is able to modulate the expression of cyclin D1 in a specific manner probably dependent on the dimeric partner, and the recruitment of specific transcriptional modulators and/or chromatin remodeling factors. Recently, it has been demonstrated that prostaglandins stimulate cyclin D1 by activating b-catenin/TCF-dependent transcription (Shao et al., 2005) Recruitment of AP-1 proteins to the endogenous TBE0 site. ChIP was performed with chromatin prepared from serumdeprived cells unstimulated (0 h) or serum stimulated for 2 and 4 h immunoprecipitated with antibodies, as indicated. PCR was performed from these immunoprecipitates, with input chromatin or with chromatin processed in the absence of antibody (no antibody) using a primer pair covering the TBE0 site of the cyclin D1 promoter, or primers amplifying an upstream region of the promoter. PCR products were resolved by agarose gel ethidium bromide staining. Representative of two different experiments.
AP-1 and b-catenin K Toualbi et al et al., 2000) , the underlying mechanism might also rely on a synergistic cooperation between AP-1 and b-catenin, as identified in our study.
Activation of AP-1 and nuclear b-catenin is characteristic of many tumors, and a number of genes targeted by these signalling pathways are crucial for tumor development and progression. It is likely that the synergistic mechanism between the nuclear b-catenin/ TCF and AP-1 signalling cascades illustrated in the present study may contribute to the potentiation of malignancy during tumorigenesis.
Materials and methods
Plasmids
The luciferase reporter construct À963 cyclin D1-Luc and AP1mut-ATFmut-Luc from the cyclin D1 promoter were kindly provided by R Pestell and the pcyclin D1 TBE0-4mut-Luc reporter construct, with mutations in the five proximal TBE (Tetsu and McCormick, 1999) , was a kind gift of O Tetsu and F McCormick. The c-myc promoter pc-myc-Luc construct, which includes a À2329 to þ 510 pb fragment from the human c-myc promoter, was a generous gift of M Kato (Iavarone et al., 2003) . The pc-myc-AP-1mut reporter was constructed by PCR amplification of the pc-myc-Luc plasmid using mutant primers of the AP-1 site at À1.3 kb (Acc. no. X00364). The primers used were: upper strand, 5 0 -GGACTAGTATT CAGAAAAAATTGCCAGTCAG-3 0 , and lower strand: 5 0 -GGAACAGCTGCCCTCCACACAG-3 0 . The expression vectors pcDNA/c-Jun(1-331), pcDNA/c-Jun(D3-122) and pcDNA/c-Jun(226-331) with deletion in the N-terminal region, pcDNA/c-Jun DBDmut, mutated in the DNA-binding domain, and pcDNA/c-JunDLZ, deleted of the leucine zipper domain have been previously described (Kardassis et al., 1999) . The pcDNA3/c-Fos, pcDNA3/c-Fos-DLZ, pcDNA3/ c-Fos-DDBD, pcDNA3/c-Fos-DN and pcDNA3/c-Fos-DC encoding the wild or mutated human c-Fos proteins were the generous gift of M Piechaczyk (Ferrara et al., 2003) . Expression vectors for TCF4 and TCF4DN were a gift from C Perret. The b-cat wild type (WT) and b-catT41A plasmids for expression of WT and mutated b-catenin and the pGEXb-catenin constructs for the bacterial expression of full-length and truncated GST-b-catenin fragments have been previously described (Wei et al., 2003) . The c-Jun antisense construct has been previously reported (Mauviel et al., 1996) .
GST pull-down assay 35 S-labeled proteins produced in vitro using TNT-coupled/ reticulocyte lysate system (Promega, Charbonnieres-les-Bains, France) and GST-b-catenin fusion proteins linked to glutathione Sepharose beads (Amersham Biosciences, Saclay, France) were used in the binding assay as previously reported (Wei et al., 2003) .
Cell culture and reagents Cos7 cells, HepG2 and HCT116 cells were maintained in DMEM (Invitrogen, Cergy-Pontoise, France) supplemented with 10% fetal calf serum, 1% penicillin, 1% streptomycin. Antibodies to c-Jun C-terminal (SC-79) or N-terminal (Sc-44), c-Fos (SC-52), JunB (SC-73), JunD (SC-74), cyclin D1 (SC-246), TCF4 (SC-8632) and HDAC1 (SC-7872) were from Santa-Cruz Biotechnology (Santa Cruz, CA, USA). Antib-catenin antibody was purchased from BD Biosciences (Le Pont de Claix, France). Control and c-Fos-specific small interfering RNAs (siRNAs) were purchased from Ambion (Huntingdon, UK).
Transient transfections and reporter gene assays Cells (10-15 Â 10 6 ) were electroporated (Gene Pulser, Bio-Rad, Marnes-la-Coquette, France) at 230 V and 960 microfarads (for HepG2 and HCT116 cells) and 200 V and 50 microfarads (for Cos7 cells) in electroporation buffer (PBS with 10 mM Hepes), luciferase and chloramphenicol acetyl transferase assays were performed as previously described ).
Co-immunoprecipitation
Approximately 500 mg to 1 mg of total proteins from cells lysed in lysis buffer (25 mM HEPES pH 7.5, 1% Triton X-100, 2 mM ethylenediaminetetraacetic acid (EDTA), 0.1 M NaCl, 25 mM NaF, 1 mM Naorthovanadate, 1 mM dithiothreitol (DTT), and protease inhibitor mixture) were incubated with speciesspecific anti-IgG-coated magnetic beads (Dynal Biotechnology, Invitrogen, Cergy Pontoise, France) overnight at 41C. After washing, beads were suspended in Laemmli buffer, boiled and the supernatant was subjected to polyacrylamide gel electrophoresis (PAGE). Immunoprecipitated proteins were revealed by Western blotting.
Western blotting
Nuclear extracts were prepared according to Sadowski and Gilman (1993) . They were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrophoretically transferred to nitrocellulose membranes (Schleicher and Schuell). After incubation of the membranes with primary and secondary antibodies, immunoreactive bands were visualized by chemiluminescence (Amersham Pharmacia Biotech, Saclay, France).
Electrophoretic mobility shift assay Single-stranded oligonucleotides corresponding to the upper strand of the TBE0 site from the human cyclin D1 promoter (Acc. no. Z 29078) (5 0 -GGACAAGATGAAGGAAATGC-3 0 ), or the upper strand of a Oct-1 probe (5 0 -TGTCGAATG CAAATCACTAGA-3 0 ) were end-labeled with T4 polynucleotide kinase in the presence of [g-32 P]ATP (5000 Ci/mmol, Amersham Pharmacia BioSciences, Saclay, France). The labeled oligonucleotides were annealed with their respective unlabeled lower strands. EMSA was performed as previously described ) using 5-15 mg of nuclear extracts. The unlabeled probes used for competition were: TRE probe (5 0 -TAAAGCATGAGTCAGACACCTC-3 0 ), mutTRE probe (5 0 -TAAAGCATCACTCAGACACCTC-3 0 ), mutTBE0 probe (5 0 -GGACAAGATGCGGGAAATGC-3 0 ). For supershift analyses, 4 mg of antibody were incubated with the nuclear extracts for 30 min-at 41C before incubation with the 32 P-radiolabeled probe.
Chromatin immunoprecipitation assay HCT116 cells serum-starved or stimulated with 10% serum were crosslinked by 1% paraformaldehyde for 10 min at room temperature. Preparation of soluble chromatin, ChIP and recovery of precipitated DNA were performed with the ChIP-IT kit (Active Motif, Rixensart, Belgium) according to the manufacturers instructions, using 8 mg antibodies. For the PCR reaction, 35 cycles of amplification were carried out using two primers sets, one set spanning the TBE0 site of cyclin D1 (forward 5 0 -GCTTTCCATTCAGAGGTGTG-3 0 and reverse 5 0 -CCGAAAATTCCAGCAGCAGC-3 0 ) and the other set spanning the upstream region of the promoter (forward 5 0 -CCAAGTCCTTTCAAGTCGCC-3 0 and reverse 5 0 -AGG GAGCGCGTTCATTCAG-3 0 ).
